Skip to main content

Table 4 Univariate and multivariate analysis of factors associated with overall survival in 114 laryngeal cancer patients

From: PLOD2 contributes to drug resistance in laryngeal cancer by promoting cancer stem cell-like characteristics

Characteristics Univariate analysis Multivariate analysis
HR (95% CI) P values HR (95% CI) P values
Age 0.928 (0.386–2.233) 0.868 2.440 0.118
Gender 1.857 (0.248–13.910) 0.547 2.856 0.091
T stage 8.280 (2.408–28.478) 0.001* 5.624 (1.594–19.840) 0.007*
N stage 2.229 (0.910–5.461) 0.080 0.081 0.776
M stage 3.935 (1.418–10.917) 0.009* 2.744 (0.987–7.629) 0.053
Clinical stage 6.252 (1.827–21.396) 0.004* 0.398 0.528
Relapse 3.377 (1.395–8.175) 0.007* 2.153 0.142
Thyroid cartilage invasion 4.005 (1.634–9.819) 0.002* 0.699 0.403
CD44 5.845 (1.936–17.647) 0.002* 1.459 0.227
CD133 3.769 (1.436–9.891) 0.007* 0.626 0.429
PLOD2 6.720 (2.193–20.588) 0.001* 4.559 (1.356–15.325) 0.014*
  1. HR hazard ratio, CI confidence interval
  2. * p < 0.05